Cargando…
Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
CONTEXT: Mitoxantrone (MTX) is an antracyclin drug that is used for treatment of patients with chronic refractory multiple sclerosis (MS). Congestive heart failure (CHF) is a rare complication of this drug that may occur early, during therapy, or late, months or years after termination of therapy. A...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941302/ https://www.ncbi.nlm.nih.gov/pubmed/31921403 http://dx.doi.org/10.4103/ijpvm.IJPVM_477_17 |